BioAgilytix

We are back from the Boston Society Gene and Cell Therapy Conference! The event was a great success, covering a broad range of insightful scientific discussions. Our team was particularly interested in the exchange of knowledge on multiple aspects of cell therapies, from therapeutic design to bioanalysis and CMC. We’re excited to continue these conversations and looking forward to next year’s event! Did you miss us at #BSGCT2025? Be sure to reach out to our scientific team today: https://lnkd.in/e7_WbES?

Regulatory changes are reshaping the landscape for IVDs and LDTs. Navigating these changes is critical for clinical trials. Join us at #WRIB2025 where Scientific Officer, Amanda Hays, PhD, will share insights on the complexities of the EU IVDR and the FDA’s new LDT Final Rule through case studies and lessons learned in her presentation, ???????????????????? ?????? ??????/???????? ????????????????????????: ?? ?????? ??????????????????????. Explore how to stay ahead in an evolving regulatory environment and learn how BioAgilytix can support your regulatory strategy and diagnostic development needs by scheduling a meeting with our team onsite! https://bit.ly/3DJy54h #immunogenicity #pharmacokinetics #biomarkers #WRIB

Last week we wrapped up another successful SOT annual meeting. Although we missed interacting with our colleagues from regulatory agencies, we were able to enjoy many interesting topics and discussions around pharmaceutical safety testing and strategies for boosting success during preclinical IND-enabling stages of drug development. We look forward to seeing everyone again next year! Did you miss us at SOT? Be sure to reach out to our scientific team today: https://bit.ly/44luZLt? #2025SOT #Toxicology #Pharmacokinetics #Biomarkers #CellBasedAssays

Join us at #WRIB, where Stephen Krcha will be sharing a poster titled "Development of a Novel Sample Pretreatment Method to Optimize Drug Tolerance and Maintain Sensitivity for Immunogenicity Assessment of Biotherapeutics". In this poster, we focus on novel strategies for improving drug tolerance in ADA assays. Our innovative approach combines SPEAD methodology with bridging assay techniques to achieve enhanced drug tolerance while preserving sensitivity—addressing a challenge with biotherapeutics that have increased safety profiles and used with higher dosing levels. Connect with our team at WRIB to learn how BioAgilytix can support your regulatory strategy and diagnostic development needs! ???????????????? ?? ?????????????? ??????????: https://bit.ly/3DJy54h #immunogenicity #pharmacokinetics #biomarkers #WRIB

?????????????? ???????? ??????-???????????????? ??????????????. Discover how to reduce turnaround time and streamline analysis while maintaining scientific rigor for transporter and in vitro DDI assays. Download our poster to learn more: https://bit.ly/4ixwSw7 #Preclinical #DMPK #LCMS #MassSpectrometry #ADME #INDEnabling #DrugDrugInteraction

Struggling with cell viability detection in potency assays? Join Gopit Shah, PhD at the CASSS – Sharing Science Solutions Bioassay Symposium in Gaithersburg, Maryland! Be sure to stop by to view our presentation: "???????????????????? ???? ?????????? ????????????????????-?????????? ?????????????????? ???????? ?????? ???????? ?????????????????? ???????????????????? ???? ?? ????????-?????????? ?????????????? ??????????". In this presentation, Gopit will present findings on how different luciferase systems perform in growth factor potency testing, including differences in signal to noise ratio performance. Take this opportunity to learn which detection reagents best suit your specific cell-based assay needs. Schedule a meeting with our team today: https://bit.ly/3FkVLwp #CASSS #Bioassays2025 #Biopharmaceuticals #Biotechnology #DrugDevelopment

#BioAgilytix is onsite at the BEBPA 2025 US Bioassay Conference in Tucson, Arizona! Stop by and speak with our experts to discover how our comprehensive global CMC services and collaborative partnership approach can accelerate your program's success. Our team of experts is ready to discuss customized solutions for your specific challenges! https://bit.ly/4a0eV5G Jessica Bridges Weaver Justin Pittman (he/him) Bhoomi Jani

Another successful "A Day in the Life" event with Triangle Women in STEM! We were proud to be a sponsor of this great initiative, helping to connect and inspire women pursuing careers in STEM. A big shoutout to Aidan Huene, for sharing her career journey as a panelist—your insights and experiences were invaluable! Julia Webber and Jen Russum also had some great conversations with upcoming graduates, offering valuable tips and tricks for breaking into the industry. We hope attendees left with a deeper understanding of the many exciting career opportunities at #BioAgilytix and in the broader STEM field. Looking forward to the next one! #WomenInSTEM #TriangleWomenInSTEM #STEMCareers

It was a successful UK Roadshow last week for our #BioAgilytix and 360biolabs, a BioAgilytix company teams! Scientific Officer, Robert Nelson, PhD, UK Business Development Director Valeria Ventura, PhD, and Scientific Operations Christopher Tiedje, PhD started in London at the I-HUB Lunch & Learn sharing insights on risk minimization and regulatory pathways. The roadshow continued in Cambridge and Oxford with EVP, Commercial, Angela Luttick, at the Australian Delegation’s Tea and Talks series expanding on our global capabilities. Special thanks to the Australian delegation team for the collaboration and informative sessions. BioAgilytix has 6 state-of-the-art laboratories in major biotech and pharmaceutical regions in 3 countries and 1000+ team members around the globe. Our laboratories at 360biolabs offer the Australian advantage with speed, quality, and cost incentives for Early Phase clinical studies. Seamlessly transition your Phase 1 assays to our global BioAgilytix laboratories in Europe and the USA for Phase 2+. We look forward to further strengthening our support for scientific innovations in the UK with our global capabilities! Did you miss us in the UK? Reach out to our global team to discuss the needs of your next project: https://lnkd.in/e7_WbES #GlobalReach #AustalianAdvantage #360biolabs #DrugDevelopment #ThisisIHUB

The day is here! Visit the #BioAgilytix team at Booth 5 at the 2025 Boston Society Gene and Cell Therapy Conference. Our experts are onsite and eager to discuss our tailored bioanalytical strategies for ATMPs, offering customized solutions as part of a comprehensive service package to support your next study. We look forward to connecting! Learn more here: https://bit.ly/3zVY1rK #BSGCT2025 #GeneTherapy #CellTherapy #Biotech